[Clinical evaluation of glypidizine, a new oral hypoglycemic agent].
D000284:Administration, Oral; D000328:Adult; D000367:Age Factors; D000368:Aged; D000704:Analysis of Variance; D001827:Body Height; D001835:Body Weight; D002986:Clinical Trials as Topic; D003510:Cyclohexanes / Q000008:administration & dosage / Q000627:therapeutic use; D003920:Diabetes Mellitus / Q000188:drug therapy*; D005069:Evaluation Studies as Topic; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000008:administration & dosage / Q000627:therapeutic use; D013453:Sulfonylurea Compounds / Q000008:administration & dosage* / Q000627:therapeutic use
D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D011719:Pyrazines; D013453:Sulfonylurea Compounds
Valoración clíncia de la glipizida, nuevo hipogluceminate oral.